Tag: Antibody Oligonucleotide Conjugates
-
Clinical Drug Development Process March 02, 2023: First targeted delivery of siRNA into muscle
In the clinical trial a total of 38 patients participated and the treatment focused on using a new class of RNA therapeutics named as Antibody Oligonucleotide Conjugates (AOCs™).